Dexamethasone is widely administered to children during elective tonsillectomy to reduce the rate of postoperative nausea and vomiting, as well as decrease postoperative use of pain medications. Over the past two decades, there has been a wealth of literature advocating the practice that has led to endorsement by a variety of anesthesia and otolaryngology professional associations. However, the publication of a trial that was halted due to a potential dose-dependent association between postoperative hemorrhage and dexamethasone raised significant scrutiny regarding the practice in 2008. As a result, significant re-evaluation of existing data as well as the development and execution of additional trials have been pursued in recent years. Ultimately, the body of evidence that currently exists appears to support the concept that a single dose of perioperative dexamethasone is not associated with undue risk. A decision to withdraw dexamethasone from use in pediatric tonsillectomy needs to be weighed against the potential of causing increased postoperative nausea, vomiting, pain, and resultant hospital readmission. At this point, surgeons and anesthesiologists should feel comfortable giving perioperative dexamethasone but must remain vigilant for bleeding complications.

Keywords:
Steroid, Dexamethasone, Postoperative hemorrhage
1.
Allford M, Guruswamy V: A national survey of the anesthetic management of tonsillectomy surgery in children. Paediatr Anaesth 2009;19:145-152.
2.
Kay DJ, Mehta V, Goldsmith AJ: Perioperative adenotonsillectomy management in children: current practices. Laryngoscope 2003;113:592-597.
3.
Gan TJ, et al: Society for Ambulatory Anesthesia guidelines for the management of postoperative nausea and vomiting. Anesth Analg 2007;105:1615-1628.
4.
Baugh RF, Archer SM, Mitchell RB, Rosenfeld RM, Amin R, Burns JJ, Darrow DH, Giordano T, Litman RS, Li KK, Mannix ME, Schwartz RH, Setzen G, Wald ER, Wall E, Sandberg G, Patel MM, American Academy of Otolaryngology-Head and Neck Surgery Foundation: Clinical practice guideline: tonsillectomy in children. Otolaryngol Head Neck Surg 2011;144(suppl 1):S1-S30.
5.
Steward DL, Welge JA, Myer CM: Steroids for improving recovery following tonsillectomy in children. Cochrane Database Syst Rev 2003;1:CD003997.
6.
Papangelou L: Steroid therapy in tonsillectomy. Laryngoscope 1972;82:297-301.
7.
Kim MS, et al: There is no dose-escalation response to dexamethasone (0. 0625-1.0 mg/kg) in pediatric tonsillectomy or adenotonsillectomy patients for preventing vomiting, reducing pain, shortening time to first liquid intake, or the incidence of voice change. Anesth Analg 2007;104:1052-1058.
8.
Goldman AC, Govindaraj S, Rosenfeld RM: A meta-analysis of dexamethasone use with tonsillectomy. Otolaryngol Head Neck Surg 2000;123:682-686.
9.
Steward DL, Welge JA, Myer CM: Do steroids reduce morbidity of tonsillectomy? Meta-analysis of randomized trials. Laryngoscope 2001;111:1712-1718.
10.
Afman CE, Welge JA, Steward DL: Steroids for post-tonsillectomy pain reduction: meta-analysis of randomized controlled trials. Otolaryngol Head Neck Surg 2006;134:181-186.
11.
Splinter WM, Roberts DJ: Dexamethasone decreases vomiting by children after tonsillectomy. Anesth Analg 1996;83:913-916.
12.
April MM, et al: The effect of intravenous dexamethasone in pediatric adenotonsillectomy. Arch Otolaryngol Head Neck Surg 1996;122:117-120.
13.
Pappas AL, et al: The effect of preoperative dexamethasone on the immediate and delayed postoperative morbidity in children undergoing adenotonsillectomy. Anesth Analg 1998;87:57-61.
14.
Fazel MR, et al: The effect of dexamethasone on postoperative vomiting and oral intake after adenotonsillectomy. Int J Pediatr Otorhinolaryngol 2007;71:1235-1238.
15.
Clavisi O: Does Antibiotic and/or Steroid Therapy Reduce Pain and Secondary Hemorrhaging after Tonsillectomy? Clayton, Center for Clinical Effectiveness, 2000.
16.
Hilton M: Tonsillectomy technique - tradition versus technology. Lancet 2004;364:642-643.
17.
Hanasono MM, et al: Perioperative steroids in tonsillectomy using electrocautery and sharp dissection techniques. Arch Otolaryngol Head Neck Surg 2004;130:917-921.
18.
Litman RS, Wu CL, Catanzaro FA: Ondansetron decreases emesis after tonsillectomy in children. Anesth Analg 1994;78:478-481.
19.
Gan T, Sloan F, Dear Gde L, El-Moalem HE, Lubarsky DA: How much are patients willing to pay to avoid postoperative nausea and vomiting? Anesth Analg 2001;92:393-400.
20.
Ved SA, Walden TL, Montana J, Lea DE, Tefft MC, Kataria BK, Pudimat MA, Nicodemus HF, Milmoe GJ: Vomiting and recovery after outpatient tonsillectomy and adenoidectomy in children. Comparison of four anesthetic techniques using nitrous oxide with halothane or propofol. Anesthesiology 1996;85:4-10.
21.
Tom LW, et al: Dexamethasone in adenotonsillectomy. Int J Pediatr Otorhinolaryngol 1996;37:115-120.
22.
Bolton CM, et al: Prophylaxis of postoperative vomiting in children undergoing tonsillectomy: a systematic review and meta-analysis. Br J Anaesth 2006;97:593-604.
23.
Czarnetzki C, et al: Dexamethasone and risk of nausea and vomiting and postoperative bleeding after tonsillectomy in children: a randomized trial. JAMA 2008;300:2621-2630.
24.
Elhakim M, et al: Dexamethasone reduces postoperative vomiting and pain after pediatric tonsillectomy. Can J Anaesth 2003;50:392-397.
25.
Aouad MT, et al: The effect of dexamethasone on postoperative vomiting after tonsillectomy. Anesth Analg 2001;92:636-640.
26.
Marret E, Flahault A., Samama CM, Bonnet F: Effects of postoperative, nonsteroidal, antiinflammatory drugs on bleeding risk after tonsillectomy: meta-analysis of randomized, controlled trials. Anesthesiology 2003;98:1497-1502.
27.
Møiniche S, Rømsing J., Dahl JB, Tramèr MR: Nonsteroidal antiinflammatory drugs and the risk of operative site bleeding after tonsillectomy: a quantitative systematic review. Anesth Analg 2003;96:68-77.
28.
Brigger MT, Cunningham MJ, Hartnick CJ: Dexamethasone administration and postoperative bleeding risk in children undergoing tonsillectomy. Arch Otolaryngol Head Neck Surg 2010;136:766-772.
29.
Geva A, Brigger MT: Dexamethasone and tonsillectomy bleeding: a meta-analysis. Otolaryngol Head Neck Surg 2011;144:838-843.
30.
Gunter JB, Willging JP, Myer CM 3rd: Dexamethasone and postoperative bleeding after tonsillectomy in children. JAMA 2009;301:1764-1765, author reply 1765-1766.
31.
Beutner D, Koll C: Dexamethasone and postoperative bleeding after tonsillectomy in children. JAMA 2009;301:1764, author reply 1765-1766.
32.
Shin JI: Dexamethasone and postoperative bleeding after tonsillectomy in children. JAMA 2009;301:1764, author reply 1765-1766.
33.
Pocock S: When (not) to stop a clinical trial for benefit. JAMA 2005;294:2228-2230.
34.
Werner E: Preoperative hemostatic screening for pediatric adenotonsillar surgery: worthwhile effort or waste of resources? Pediatr Blood Cancer 2010;55:1045-1046.
35.
Wieland A, Beiden L, Cunningham M: Preoperative coagulation screening for adenotonsillectomy: a review and comparison of current physician practices. Otolaryngol Head Neck Surg 2009;140:542-547.
36.
Cooper JD, Smith KJ, Ritchey AK: A cost-effectiveness analysis of coagulation testing prior to tonsillectomy and adenoidectomy in children. Pediatr Blood Cancer 2010;55:1153-1159.
37.
Williams JD, Pope TH Jr: Prevention of primary tonsillectomy bleeding. An argument for electrocautery. Arch Otolaryngol 1973;98:306-309.
38.
Leinbach RF, Markwell SJ, Colliver JA, Lin SY: Hot versus cold tonsillectomy: a systematic review of the literature. Otolaryngol Head Neck Surg 2003;129:360-364.
39.
Lee MS, Montague ML, Hussain SS: Post-tonsillectomy hemorrhage: cold versus hot dissection. Otolaryngol Head Neck Surg 2004;131:833-836.
40.
Shinhar S, Scotch BM, Belenky W, Madgy D, Haupert M: Harmonic scalpel tonsillectomy versus hot electrocautery and cold dissection: an objective comparison. Ear Nose Throat J 2004;83:712-715.
41.
Ragab S: Bipolar radiofrequency dissection tonsillectomy: a prospective randomized trial. Otolaryngol Head Neck Surg 2005;133:961-965.
42.
Schmidt R, et al: Complications of tonsillectomy: a comparison of techniques. Arch Otolaryngol Head Neck Surg 2007;133:925-928.
43.
Solares CA, et al: Safety and efficacy of powered intracapsular tonsillectomy in children: a multi-center retrospective case series. Int J Pediatr Otorhinolaryngol 2005;69:21-26.
44.
Liu JH, et al: Posttonsillectomy hemorrhage: what is it and what should be recorded? Arch Otolaryngol Head Neck Surg 2001;127:1271-1275.
45.
Myssiorek D, Alvi A: Post-tonsillectomy hemorrhage: an assessment of risk factors. Int J Pediatr Otorhinolaryngol 1996;37:35-43.
46.
Glade RS, et al: Coblation adenotonsillectomy: an improvement over electrocautery technique? Otolaryngol Head Neck Surg 2006;134:852-855.
47.
Granell J, et al: Safety of outpatient tonsillectomy in children: a review of 6 years in a tertiary hospital experience. Otolaryngol Head Neck Surg 2004;131:383-387.
48.
Mills N, et al: Day stay pediatric tonsillectomy - a safe procedure. Int J Pediatr Otorhinolaryngol 2004;68:1367-1373.
49.
Windfuhr JP, Chen YS: Incidence of post-tonsillectomy hemorrhage in children and adults: a study of 4,848 patients. Ear Nose Throat J 2002;81:626-628, 630, 632.
50.
Lowe D, van der Meulen J: Tonsillectomy technique as a risk factor for postoperative haemorrhage. Lancet 2004;364:697-702.
51.
Gunter JB, et al: A factorial study of ondansetron, metoclopramide, and dexamethasone for emesis prophylaxis after adenotonsillectomy in children. Paediatr Anaesth 2006;16:1153-1165.
52.
Hessén Söderman AC, Ericsson E, Hemlin C, Hultcrantz E, Månsson I, Roos K, Stalfors J: Reduced risk of primary postoperative hemorrhage after tonsil surgery in Sweden: results from the National Tonsil Surgery Register in Sweden covering more than 10 years and 54,696 operations. Laryngoscope 2011;121:2322-2326.
53.
Bhattacharyya N: Ambulatory pediatric otolaryngologic procedures in the United States: characteristics and perioperative safety. Laryngoscope 2010;120:821-825.
54.
Brigger MT, Brietzke SE: Outpatient tonsillectomy in children: a systematic review. Otolaryngol Head Neck Surg 2006;135:1-7.
55.
Macassey EA, et al: 15-year audit of post-tonsillectomy haemorrhage at Dunedin Hospital. Aust NZ J Surg 2007;77:579-582.
56.
Collison PJ, Mettler B: Factors associated with post-tonsillectomy hemorrhage. Ear Nose Throat J 2000;79:640-642, 644, 646.
57.
Kennedy KS, Strom C: A comparison of postoperative bleeding incidence between general and local anesthesia tonsillectomies. Otolaryngol Head Neck Surg 1990;102:654-657.
58.
Blatt IM: Postoperative bleeding incidence after local anesthesia tonsillectomies. Otolaryngol Head Neck Surg 1991;105:135-136.
59.
Jilma B, Cvitko T, Winter-Fabry A, Petroczi K, Quehenberger P, Blann AD: High dose dexamethasone increases circulating P-selectin and von Willebrand factor levels in healthy men. Thromb Haemost 2005;94:797-801.
60.
Sakamoto K, Osaki M, Hozumi A, Goto H, Fukushima T, Baba H, Shindo H: Simvastatin suppresses dexamethasone-induced secretion of plasminogen activator inhibitor-1 in human bone marrow adipocytes. BMC Musculoskelet Disord 2011;12:82.
61.
Hozumi A, Osaki M, Sakamoto K, Goto H, Fukushima T, Baba H, Shindo H: Dexamethasone-induced plasminogen activator inhibitor-1 expression in human primary bone marrow adipocytes. Biomed Res 2010;31:281-286.
62.
Ahmed KA, Dreher ME, King RF, Flick R, Marienau ME, Schears GJ, Orvidas LJ: Dexamethasone and postoperative bleeding risk after adenotonsillectomy in children. Laryngoscope 2011;121:1060-1061.
63.
Windfuhr JP, Chen YS, Propst EJ, Güldner C: The effect of dexamethasone on post-tonsillectomy nausea, vomiting and bleeding. Braz J Otorhinolaryngol 2011;77:373-379.
64.
Diakos EA, Gallos ID, El-Shunnar S, Clarke M, Kazi R, Mehanna H: Dexamethasone reduces pain, vomiting and overall complications following tonsillectomy in adults: a systematic review and meta-analysis of randomised controlled trials. Clin Otolaryngol 2011;36:531-542.
65.
Shakeel M, Trinidade A, Al-Adhami A, Karamchandani D, Engelhardt T, Ah-See KW, Kubba H: Intraoperative dexamethasone and the risk of secondary posttonsillectomy hemorrhage. J Otolaryngol Head Neck Surg 2010;39:732-736.
66.
Krishna P, Lee D: Post-tonsillectomy bleeding: a meta-analysis. Laryngoscope 2001;111:1358-1361.
67.
Stewart R, et al: Dexamethasone reduces pain after tonsillectomy in adults. Clin Otolaryngol Allied Sci 2002;27:321-326.
68.
Shargorodsky J, Hartnick CJ, Lee GS: Dexamethasone and postoperative bleeding after tonsillectomy and adenotonsillectomy in children: a meta-analysis of prospective studies. Laryngoscope 2012;122:1158-1164.
69.
Plante J, Turgeon AF, Zarychanski R, Lauzier F, Vigneault L, Moore L, Boutin A, Fergusson DA: Effect of systemic steroids on post-tonsillectomy bleeding and reinterventions: systematic review and meta-analysis of randomised controlled trials. BMJ 2012;345:e5389.
70.
Gallagher TQ, Hill C, Ojha S, Ference E, Keamy DG, Williams M, Hansen M, Maurer R, Collins C, Setlur J, Capra GG, Brigger MT, Hartnick CJ: Perioperative dexamethasone administration and risk of bleeding following tonsillectomy in children: a randomized controlled trial. JAMA 2012;308:1221-1226.
71.
Czarnetzki C, Elia N, Tramèr MR: Bleeding risk and dexamethasone use in children undergoing tonsillectomy. JAMA 2013;309:437.
72.
Gallagher TQ, Brigger MT, Hartnick CJ: Bleeding risk and dexamethasone use in children undergoing tonsillectomy - reply. JAMA 2013;309:437-438.
© 2013 S. Karger AG, Basel
2013
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.